White Papers

    • Date Published
    • May 2017

    Recommendations for Use of the NCPDP Telecommunication Standard to Prevent Use of Copayment Coupons by Medicare Part D Beneficiaries and Applicability to other Federal Programs

    This paper provides recommendations for the best available long term solution to prevent the use of copayment coupons for drugs paid for by Medicare Part D.

    • Date Published
    • November 2016

    NCPDP’s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances

    This latest update (2016) to NCPDP’s PDMP white paper includes an Executive Summary overview, and incorporates updates that address the Comprehensive Addiction and Recovery Act (CARA) enhancements for PDMPs and recent feedback from our EDvocacy efforts. NCPDP’s model solution leverages best practices and existing industry standards to enhance state PDMPs, support interoperability, provide real-time reporting and risk alerts, and access to data, giving providers information in a timely manner, across state lines and across pharmacies.

    • Date Published
    • June 2016

    NCPDP Recommendations for Dose Accumulation Monitoring in the Inpatient Setting: Acetaminophen Case Model

    This paper provides the healthcare industry, in particular the pharmacy and inpatient facility sectors, with historical and background information on the patient risks associated with hidden sources of acetaminophen and recommendations for best practices to mitigate those risks through facility management and electronic medical record systems.

    This white paper appears in the August 1, 2016 issue of the American Journal of Health-System Pharmacy (AJHP). Click here to access the white paper on AJHP’s website.

For problems with the site please contact us at webmaster@ncpdp.org